These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6772658)

  • 1. The use of a pre-column for the direct high-performance liquid chromatographic determination of the anti-depressants clovoxamine and fluvoxamine in plasma.
    de Jong GJ
    J Chromatogr; 1980 Aug; 183(2):203-11. PubMed ID: 6772658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorimetric determination of fluvoxamine or clovoxamine in human plasma after thin-layer chromatographic or high-performance liquid chromatographic separation.
    Schweitzer C; Spahn H; Mutschler E
    J Chromatogr; 1986 Oct; 382():405-11. PubMed ID: 3097046
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of clovoxamine concentration in human plasma by electron capture gas chromatography.
    Hurst HE; Jones DR; Jarboe CH; deBree H
    Clin Chem; 1981 Jul; 27(7):1210-2. PubMed ID: 7237785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High performance liquid chromatographic determination of fluvoxamine in human plasma.
    Pommery J; Lhermitte M
    Biomed Chromatogr; 1989 Jul; 3(4):177-9. PubMed ID: 2511937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive one-step extraction procedure for column liquid chromatographic determination of fluvoxamine in human and rat plasma.
    Van der Meersch-Mougeot V; Diquet B
    J Chromatogr; 1991 Jul; 567(2):441-9. PubMed ID: 1939476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of fluvoxamine in human plasma by high-performance liquid chromatography with ultraviolet detection.
    Foglia JP; Birder LA; Perel JM
    J Chromatogr; 1989 Oct; 495():295-302. PubMed ID: 2515199
    [No Abstract]   [Full Text] [Related]  

  • 7. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man.
    Saletu B; Grünberger J; Rajna P; Karobath M
    J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose.
    Titier K; Castaing N; Scotto-Gomez E; Pehourcq F; Moore N; Molimard M
    Ther Drug Monit; 2003 Oct; 25(5):581-7. PubMed ID: 14508381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clovoxamine kinetics in an early clinical trial.
    Hurst HE; Jones DR; Wright JH; Jarboe CH
    Clin Pharmacol Ther; 1983 Aug; 34(2):266-71. PubMed ID: 6872422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic determination of free and total polyamines in human serum as fluorescamine derivatives.
    Kai M; Ogata T; Haraguchi K; Ohkura Y
    J Chromatogr; 1979 Jun; 163(2):151-60. PubMed ID: 541366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with fluvoxamine, clovoxamine, and placebo: interaction with digoxin and effects on sleep and alertness.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Labedski L
    J Clin Pharmacol; 1989 Jan; 29(1):91-5. PubMed ID: 2496149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo controlled study of the cardiovascular effects of fluvoxamine and clovoxamine in human volunteers.
    Robinson JF; Doogan DP
    Br J Clin Pharmacol; 1982 Dec; 14(6):805-8. PubMed ID: 6817771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous plasma level analysis of clomipramine, N-desmethylclomipramine, and fluvoxamine by reversed-phase liquid chromatography.
    Palego L; Marazziti D; Biondi L; Giannaccini G; Sarno N; Armani A; Lucacchini A; Cassano GB; Dell'Osso L
    Ther Drug Monit; 2000 Apr; 22(2):190-4. PubMed ID: 10774632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid-chromatographic determination of eight tri- and tetracyclic antidepressants and their major active metabolites.
    Sutfin TA; D'Ambrosio R; Jusko WJ
    Clin Chem; 1984 Mar; 30(3):471-4. PubMed ID: 6697502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-column derivatization with fluorescamine and high-performance liquid chromatographic analysis of drugs. Application to tocainide.
    Sedman AJ; Gal J
    J Chromatogr; 1982 Nov; 232(2):315-26. PubMed ID: 6818239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High performance liquid chromatography with ultraviolet detection used for laboratory routine determination of fluvoxamine in human plasma.
    Belmadani A; Combourieu I; Bonini M; Creppy EE
    Hum Exp Toxicol; 1995 Jan; 14(1):34-7. PubMed ID: 7748614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPLC method for the determination of fluvoxamine in human plasma and urine for application to pharmacokinetic studies.
    Ulu ST
    J Pharm Biomed Anal; 2007 Mar; 43(4):1444-51. PubMed ID: 17157470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated determination of fluvoxamine in plasma by column-switching high-performance liquid chromatography.
    Härtter S; Wetzel H; Hiemke C
    Clin Chem; 1992 Oct; 38(10):2082-6. PubMed ID: 1394994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated analysis of fluvoxamine in rat plasma using a column-switching system and ion-pair high-performance liquid chromatography.
    Liu S; Shinkai N; Kakubari I; Saitoh H; Noguchi K; Saitoh T; Yamauchi H
    Biomed Chromatogr; 2008 Dec; 22(12):1442-9. PubMed ID: 18655223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorimetric determination of mexiletine in serum by high-performance liquid chromatography using pre-column derivatization with fluorescamine.
    Shibata N; Akabane M; Minouchi T; Ono T; Shimakawa H
    J Chromatogr; 1991 May; 566(1):187-94. PubMed ID: 1885710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.